Jules A. Musing, Director at TherapeuticsMD, Inc. (TXMD), bought 5,282 shares at $2.15 ($11K) on 2013-08-26, disclosed to the SEC on 2013-08-27.
Open-market purchase of $11k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 4,330 | $9K | 82.0% |
| 2 | $2.15 | 952 | $2K | 18.0% |
| Total | $2.15 avg | 5,282 | $11K | 100% |
| Filing → |